StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
7
Publishing Date
2022 - 01 - 19
1
2021 - 12 - 23
1
2021 - 12 - 02
1
2021 - 09 - 24
1
2021 - 05 - 05
1
2021 - 02 - 02
1
2020 - 12 - 17
1
Sector
Health technology
7
Tags
Australia
1
Bioscience
1
Clinical-trials-phase-ii
1
Covid
4
Covid-19
3
Deadline
1
Disease
1
Expansion
1
Grant
1
Granted
1
Infectious disease
1
Influenza
1
Lancet
1
N/a
6
Phase 2
1
Phase 2b
1
Phase 3
1
Results
2
Tga
1
Trial
2
Trial results
1
Vaccine
5
Entities
Novavax, inc.
7
Symbols
AAPL
31
ABB
43
ABBV
32
ABLZF
37
ABT
49
ACM
16
ACN
28
AMGN
23
ARVL
59
AVGO
21
AZN
19
AZNCF
16
BAX
25
BNPQF
18
BNPQY
18
CLVLF
23
CLVLY
23
CMI
16
CNS
19
DELL
23
DNZOF
17
DNZOY
17
ERIC
26
FNCTF
141
GILD
17
GLAXF
25
GOOG
32
GOOGL
32
GSK
26
HCM
19
HON
51
INCY
73
JCI
19
JNJ
66
LLY
112
LMNR
27
LTUM
18
LYV
18
MDT
22
MESO
26
MMM
19
MS
92
MSFT
20
NVS
47
NVSEF
44
PCRFF
19
PCRFY
19
PD
18
PHG
18
PPRUF
21
PPRUY
21
RYLPF
24
SAP
34
SAPGF
31
SNEJF
18
SNY
87
SNYNF
84
SYK
20
TEVJF
17
TMO
38
Exchanges
Nasdaq
7
Crawled Date
2022 - 01 - 20
1
2021 - 12 - 24
1
2021 - 12 - 02
1
2021 - 09 - 24
1
2021 - 05 - 06
1
2021 - 02 - 02
1
2020 - 12 - 17
1
Crawled Time
00:00
3
00:20
4
01:00
7
02:00
2
03:00
2
04:20
2
05:00
4
06:00
2
07:00
1
08:00
2
10:00
2
11:00
7
12:00
13
12:03
1
12:15
1
12:20
6
12:30
1
12:57
1
13:00
18
13:03
3
13:15
3
13:20
5
13:30
2
14:00
21
14:03
1
14:15
1
14:20
3
14:30
6
15:00
12
15:20
3
15:30
2
16:00
8
16:20
2
17:00
5
18:00
7
19:00
10
20:00
6
21:00
14
21:03
2
22:00
15
22:01
2
23:00
14
23:01
1
Source
www.biospace.com
1
www.globenewswire.com
2
www.prnewswire.com
4
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
symbols :
Nvax
crawled time :
01:00
save search
Australia Therapeutic Goods Administration (TGA) Grants Provisional Registration for Novavax COVID-19 Vaccine
Published:
2022-01-19
(Crawled : 01:00)
- prnewswire.com
NVAX
|
$3.98
2.31%
640K
|
Health Technology
|
-95.79%
|
O:
2.59%
H:
3.89%
C:
-4.6%
covid-19
covid
tga
australia
vaccine
granted
grant
Novavax and SK bioscience Expand Manufacturing Agreement
Published:
2021-12-23
(Crawled : 01:00)
- prnewswire.com
NVAX
|
$3.98
2.31%
640K
|
Health Technology
|
Email alert
Add to watchlist
bioscience
expansion
CLAIMSFILER ALERTS NOVAVAX Investors to Lead Plaintiff Deadline in Class Action Lawsuit Against Novavax, Inc. - NVAX
Published:
2021-12-02
(Crawled : 01:00)
- prnewswire.com
NVAX
|
$3.98
2.31%
640K
|
Health Technology
|
-98.02%
|
O:
-6.87%
H:
3.23%
C:
-11.49%
deadline
Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases
Published:
2021-09-24
(Crawled : 01:00)
- prnewswire.com
NVAX
|
$3.98
2.31%
640K
|
Health Technology
|
-98.49%
|
O:
0.0%
H:
0.0%
C:
0.0%
disease
infectious disease
results
vaccine
influenza
phase 3
trial
lancet
New England Journal of Medicine Publishes Phase 2b Clinical Trial Results Demonstrating Efficacy of Novavax COVID-19 Vaccine Against the B.1.351 Variant
Published:
2021-05-05
(Crawled : 01:00)
- biospace.com/
NVAX
|
$3.98
2.31%
640K
|
Health Technology
|
-97.85%
|
O:
3.47%
H:
4.31%
C:
-8.13%
covid
phase 2
results
vaccine
phase 2b
trial
trial results
Novavax to Present COVID-19 Vaccine Candidate Data at New York Academy of Science
Published:
2021-02-02
(Crawled : 01:00)
- globenewswire.com
NVAX
|
$3.98
2.31%
640K
|
Health Technology
|
-98.55%
|
O:
0.44%
H:
0.86%
C:
-1.88%
covid
vaccine
covid-19
Novavax Announces Agreement with Government of New Zealand for 10.7 Million Doses of COVID-19 Vaccine
Published:
2020-12-17
(Crawled : 01:00)
- globenewswire.com
NVAX
|
$3.98
2.31%
640K
|
Health Technology
|
-96.78%
|
O:
2.98%
H:
6.57%
C:
5.84%
vaccine
covid
covid-19
Gainers vs Losers
79%
21%
Top 10 Gainers
AGBA
|
News
|
$1.22
205.0%
86M
|
Finance
EGOX
|
$0.0606
68.33%
250M
|
NVFY
|
$3.45
63.51%
20M
|
Consumer Durables
ZCMD
|
$1.98
36.55%
27M
|
Commercial Services
CHRO
|
$1.66
35.51%
70K
|
n/a
INDO
|
$5.43
33.09%
10M
|
Energy Minerals
PAPL
|
$2.07
26.22%
550K
|
RWOD
|
$10.08
26.05%
5.6M
|
n/a
AULT
|
$0.304
25.57%
47M
|
Manufacturing
HUSA
4
|
$2.07
23.95%
2.1M
|
Energy Minerals
Your saved searches
Save your searches and get alerts when important news are released.